文献速递脑血管病

儿童卒中超急性期再通策略:证据时代的观察与思考

Hyperacute Recanalization Strategies and Childhood Stroke in the Evidence Age.
PubMed 文献 · Stroke · 2020-12-22

儿童动脉缺血性卒中长期缺乏对照药物研究证据(镰状细胞病除外),但近期两项高质量观察性研究为再通治疗提供了有希望的数据:TIPSTER显示静脉溶栓后严重颅内出血风险低,Save Childs研究报道儿童取栓数据令人鼓舞。作者主张不应在严格筛选的患儿中回避溶栓/取栓,但需通过成人/儿科共享方案和病房协作提前规范流程。

要点

  • 儿童动脉缺血性卒中缺乏高级别证据,仅镰状细胞病有对照药物研究。
  • TIPSTER显示儿童静脉溶栓后严重颅内出血风险低,Save Childs研究取栓数据令人鼓舞。
  • 应在严格筛选患儿中使用溶栓/取栓,并提前制定成人/儿科共享方案。

核心结论

  • 儿童卒中领域除镰状细胞病外无对照药物研究,但近期高质量观察性研究支持在严格筛选的患儿中使用溶栓/取栓。

研究设计与样本

  • 本文为针对儿童动脉缺血性卒中超急性期再通策略的论述,引用TIPSTER和Save Childs两项高质量观察性研究。

主要发现

  • TIPSTER显示儿童静脉溶栓后严重颅内出血风险低。
  • Save Childs研究报告儿童取栓数据令人鼓舞。

临床怎么用

  • 不应在严格筛选的动脉缺血性卒中患儿中回避溶栓/取栓工具。
  • 需通过成人/儿科共享方案和病房协作提前规范流程,确保在患儿到达前明确合适候选者。
  • 这些预案不应低估成人指南中的禁忌证,并在面对儿童特异性病因(如局灶性脑动脉病)时纳入必要的儿科专业知识。

局限性

  • 儿童卒中领域缺乏高级别证据,除镰状细胞病外无对照药物研究。
  • 现有支持再通治疗的证据来自观察性研究,而非随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

No controlled pharmacological studies are available in the field of pediatric stroke, except for sickle cell disease. Therefore, while pharmacological and mechanical recanalization treatments have repeatedly shown clinical benefit in adults with arterial ischemic stroke, pediatric strokologists still cannot base their therapeutic management (including hyperacute strategies) on high-level evidence. Once again, pediatricians face the same dichotomic choice: adapting adult procedures now versus waiting-for a long time-for the corresponding pediatric trials. One way out is building a compromise based on observational studies with large, longitudinal, comprehensive, real-life, and multisource dataset. Two recent high-quality observational studies have delivered promising conclusions on recanalization treatments in pediatric arterial ischemic stroke. TIPSTER (Thrombolysis in Pediatric Stroke Extended Results) showed that the risk of severe intracranial hemorrhage after intravenous thrombolysis is low; the Save Childs Study reported encouraging data about pediatric thrombectomy. Beyond the conclusion of a satisfactory global safety profile, a thorough analysis of the methods, populations, results, and therapeutic complications of these studies helps us to refine indications/contraindications and highlights the safeguards we need to rely on when discussing thrombolysis and thrombectomy in children. In conclusion, pediatric strokologists should not refrain from using clot lysis/retrieval tools in selected children with arterial ischemic stroke. But the implementation of hyperacute care is only feasible if the right candidate is identified through the sharing of common adult/pediatric protocols and ward collaboration, formalized well before the child's arrival. These anticipated protocols should never undervalue contraindications from adult guidelines and must involve the necessary pediatric expertise when facing specific causes of stroke, such as focal cerebral arteriopathy of childhood.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Chabrier S, Ozanne A, Naggara O, et al. Hyperacute Recanalization Strategies and Childhood Stroke in the Evidence Age. Stroke. 2020. PMID: 33349018. doi:10.1161/STROKEAHA.120.031133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。